» Articles » PMID: 32266028

LncRNA SOX2-OT Regulates Laryngeal Cancer Cell Proliferation, Migration and Invasion and Induces Apoptosis by Suppressing MiR-654

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2020 Apr 9
PMID 32266028
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Laryngeal carcinoma is the most common type of malignant tumor in the head and neck. Long non-coding RNAs (lncRNAs) serve crucial roles in numerous biological processes. The present study aimed to investigate the role of lncRNA SOX2-OT in laryngeal cancer and to reveal the underlying mechanisms. Reverse transcription-quantitative PCR assays were used to measure the expression levels of SOX2-OT in the laryngeal cell lines. Furthermore, cell proliferation, apoptosis, migration and invasion were assessed by CCK-8, flow cytometry, wound healing and Transwell assays, respectively. Western blot assay was performed to detect the protein expressions. In addition, a dual-luciferase reporter assay was performed to confirm the direct interaction between SOX2-OT and microRNA (miR)-654. The data demonstrated that SOX2-OT level were significantly increased in the laryngeal cell lines. Furthermore, SOX2-OT silencing markedly promoted apoptosis and suppressed the proliferation, migration and invasion of TU-177 cells. A dual-luciferase reporter assay revealed that miR-654 was a direct target of SOX2-OT. Moreover, downregulation of miR-654 could attenuate cell apoptosis and accelerate cell proliferation, migration and invasion in TU-177 cells. In summary, the present study reported that knockdown of SOX2-OT could suppress cell proliferation, migration and invasion, and induce apoptosis in laryngeal cancer by targeting miR-654.

Citing Articles

The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.

Yang J, Tan F, Chen Y, Li X, Yuan C J Physiol Biochem. 2024; .

PMID: 39702742 DOI: 10.1007/s13105-024-01059-2.


LncRNAs SOX2-OT and NEAT1 act as a potential biomarker for esophageal squamous cell carcinoma.

Kumar R, Mohanta A, Rana M, Uttam V, Tuli H, Jain A Discov Oncol. 2024; 15(1):693.

PMID: 39576275 PMC: 11584831. DOI: 10.1007/s12672-024-01589-7.


[SOX2-OT/SOX2 axis regulates lung cancer H520 cell migration Gli1-mediated epithelial-mesenchymal transition].

Dong H, Zeng L, Wu Y, Miao S, Ni N, Liu N Nan Fang Yi Ke Da Xue Xue Bao. 2022; 42(10):1431-1439.

PMID: 36329576 PMC: 9637495. DOI: 10.12122/j.issn.1673-4254.2022.10.01.


CircRNA CORO1C Regulates miR-654-3p/USP7 Axis to Mediate Laryngeal Squamous Cell Carcinoma Progression.

Zhang J, Li H, Li J, Ke S Biochem Genet. 2022; 60(5):1615-1629.

PMID: 35064359 DOI: 10.1007/s10528-021-10169-1.


Prediction of lncRNA-Disease Associations Closest Node Weight Graphs of the Spatial Neighborhood Based on the Edge Attention Graph Convolutional Network.

Li J, Kong M, Wang D, Yang Z, Hao X Front Genet. 2022; 12:808962.

PMID: 35058974 PMC: 8763691. DOI: 10.3389/fgene.2021.808962.


References
1.
Teng Y, Kang H, Chu Y . Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma. Genet Test Mol Biomarkers. 2019; 23(4):235-240. DOI: 10.1089/gtmb.2018.0103. View

2.
Jin P, Huang Y, Zhu P, Zou Y, Shao T, Wang O . CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654/IGF2BP3 signaling. Biochem Biophys Res Commun. 2018; 503(3):1570-1574. DOI: 10.1016/j.bbrc.2018.07.081. View

3.
Calkovsky V, Wallenfels P, Calkovska A, Hajtman A . Laryngeal Cancer: 12-Year Experience of a Single Center. Adv Exp Med Biol. 2016; 911:9-16. DOI: 10.1007/5584_2015_201. View

4.
Wei C, Wong H, Xu F, Liu Z, Ran L, Jiang R . IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling. Eur Rev Med Pharmacol Sci. 2018; 22(23):8169-8178. DOI: 10.26355/eurrev_201812_16509. View

5.
Zatonski T, Ciesielska U, Nowinska K, Ratajczak-Wielgomas K, Kobierzycki C, Pula B . Expression of Cell Cycle-Related Proteins p16, p27, p53 and Ki-67 in HPV-positive and -negative Samples of Papillomas of the Upper Respiratory Tract. Anticancer Res. 2016; 36(8):3917-24. View